NCT04675918

Brief Summary

: An intrahospital CA data recording protocol has been designed following the Utstein model. Database is hosted according to European legislation regarding patient data protection. It is drafted in English and Spanish. Invitation to participate has been sent to Spanish, European and Latinamerican hospitals. Variables included, asses hospital characteristics, the resuscitation team, patient's demographics and background, CPR, post-resuscitation care, mortality, survival and long-term evolution. Survival at hospital discharge will be evaluated as a primary outcome and survival with good neurological status as a secondary outcome, analyzing the different factors involved in them

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
32mo left

Started Feb 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress67%
Feb 2021Dec 2028

First Submitted

Initial submission to the registry

November 27, 2020

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 19, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

February 1, 2021

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Expected
Last Updated

January 19, 2021

Status Verified

January 1, 2021

Enrollment Period

4.9 years

First QC Date

November 27, 2020

Last Update Submit

January 15, 2021

Conditions

Keywords

pediatric cardiac arrestoutcomessurvivalcardiopulmonary resuscitation

Outcome Measures

Primary Outcomes (1)

  • Survival

    Survival

    Through study completition an average of 3 years

Secondary Outcomes (1)

  • Neurological outcome

    5 years

Interventions

Definition of characteristics of cardiac arrest and resuscitation as well as post-resuscitational care and follow up.

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

All patients who suffer a cardiac arrest in hospital premises and are resuscitated with at least 1 minute of cardiopulmonary resuscitation measures.

You may qualify if:

  • all children aged 1 month to 18 years who suffer a CA in hospital

You may not qualify if:

  • Patients being treated with extracorporeal circulatory support (ECMO or ventricular assistance) at the time of CA.
  • Duration of resuscitation \< 1minute

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gregorio Marañon Hospital

Madrid, 28009, Spain

RECRUITING

Related Publications (1)

  • Del Castillo J, Sanz D, Herrera L, Lopez-Herce J; Grupo de Estudio de Parada Cardiaca Intrahospitalaria en la Infancia. Pediatric In-Hospital Cardiac Arrest International Registry (PACHIN): protocol for a prospective international multicenter register of cardiac arrest in children. BMC Cardiovasc Disord. 2021 Jul 31;21(1):365. doi: 10.1186/s12872-021-02173-5.

MeSH Terms

Conditions

Heart ArrestPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Interventions

Heart Arrest, Induced

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesLeukemia, LymphoidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesLymphoproliferative DisordersLymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Intervention Hierarchy (Ancestors)

Cardiac Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeThoracic Surgical Procedures

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

November 27, 2020

First Posted

December 19, 2020

Study Start

February 1, 2021

Primary Completion

January 1, 2026

Study Completion (Estimated)

December 31, 2028

Last Updated

January 19, 2021

Record last verified: 2021-01

Locations